These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 28072553)

  • 1. Decreased Killing Activity of Micafungin Against Candida guilliermondii, Candida lusitaniae, and Candida kefyr in the Presence of Human Serum.
    Saleh Q; Kovács R; Kardos G; Gesztelyi R; Kardos T; Bozó A; Majoros L
    Microb Drug Resist; 2017 Sep; 23(6):764-770. PubMed ID: 28072553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Killing Activity of Micafungin Against Candida albicans, C. dubliniensis and Candida africana in the Presence of Human Serum.
    Kovács R; Saleh Q; Bozó A; Tóth Z; Gesztelyi R; Kardos T; Kardos G; Takacs I; Majoros L
    Mycopathologia; 2017 Dec; 182(11-12):979-987. PubMed ID: 28699056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wild-type MIC distributions and epidemiological cutoff values for the echinocandins and Candida spp.
    Pfaller MA; Boyken L; Hollis RJ; Kroeger J; Messer SA; Tendolkar S; Jones RN; Turnidge J; Diekema DJ
    J Clin Microbiol; 2010 Jan; 48(1):52-6. PubMed ID: 19923478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Examination of the in vitro fungicidal activity of echinocandins against Candida lusitaniae by time-killing methods.
    Cantón E; Pemán J; Hervás D; Espinel-Ingroff A
    J Antimicrob Chemother; 2013 Apr; 68(4):864-8. PubMed ID: 23228935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of 50% human serum on the killing activity of micafungin against eight Candida species using time-kill methodology.
    Földi R; Szilágyi J; Kardos G; Berényi R; Kovács R; Majoros L
    Diagn Microbiol Infect Dis; 2012 Aug; 73(4):338-42. PubMed ID: 22726529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the Sensititre Yeast One microdilution method for susceptibility testing of Candida species to anidulafungin, caspofungin, and micafungin.
    García-Agudo L; García-Martos P; Martos-Cañadas J; Aznar-Marín P; Marín-Casanova P; Rodríguez-Iglesias M
    Rev Esp Quimioter; 2012 Dec; 25(4):256-60. PubMed ID: 23303256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Killing Activity of Micafungin Against Six Candida Species Isolated from Peritoneal and Pleural Cavities in RPMI-1640, 10 and 30% Serum.
    Tóth Z; Kardos T; Kovács R; Kardos G; Nagy F; Prépost E; Barta Z; Takacs I; Majoros L
    Mycopathologia; 2018 Dec; 183(6):905-912. PubMed ID: 30382508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global surveillance of in vitro activity of micafungin against Candida: a comparison with caspofungin by CLSI-recommended methods.
    Pfaller MA; Boyken L; Hollis RJ; Messer SA; Tendolkar S; Diekema DJ
    J Clin Microbiol; 2006 Oct; 44(10):3533-8. PubMed ID: 17021079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Species-specific and drug-specific differences in susceptibility of Candida biofilms to echinocandins: characterization of less common bloodstream isolates.
    Simitsopoulou M; Peshkova P; Tasina E; Katragkou A; Kyrpitzi D; Velegraki A; Walsh TJ; Roilides E
    Antimicrob Agents Chemother; 2013 Jun; 57(6):2562-70. PubMed ID: 23529739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility to echinocandins of Candida spp. strains isolated in Italy assessed by European Committee for Antimicrobial Susceptibility Testing and Clinical Laboratory Standards Institute broth microdilution methods.
    Montagna MT; Lovero G; Coretti C; Martinelli D; De Giglio O; Iatta R; Balbino S; Rosato A; Caggiano G
    BMC Microbiol; 2015 May; 15():106. PubMed ID: 25990252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo effects of echinocandins against Candida parapsilosis sensu stricto, Candida orthopsilosis and Candida metapsilosis.
    Spreghini E; Orlando F; Tavanti A; Senesi S; Giannini D; Manso E; Barchiesi F
    J Antimicrob Chemother; 2012 Sep; 67(9):2195-202. PubMed ID: 22635526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of serum on in vitro susceptibility testing of echinocandins for Candida parapsilosis and Candida guilliermondii.
    Saribas Z; Yurdakul P; Cetin-Hazirolan G; Arikan-Akdagli S
    Mycoses; 2012 Mar; 55(2):156-60. PubMed ID: 21668525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterising the post-antifungal effects of micafungin against Candida albicans, Candida glabrata, Candida parapsilosis and Candida krusei isolates.
    Nguyen KT; Ta P; Hoang BT; Cheng S; Hao B; Nguyen MH; Clancy CJ
    Int J Antimicrob Agents; 2010 Jan; 35(1):80-4. PubMed ID: 19889519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poor in vivo efficacy of caspofungin, micafungin and amphotericin B against wild-type Candida krusei clinical isolates does not correlate with in vitro susceptibility results.
    Kardos T; Kovács R; Kardos G; Varga I; Bozó A; Tóth Z; Nagy F; Majoros L
    J Chemother; 2018 Jul; 30(4):233-239. PubMed ID: 30025501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Killing kinetics of caspofungin, micafungin, and amphotericin B against Candida guilliermondii.
    Cantón E; Pemán J; Sastre M; Romero M; Espinel-Ingroff A
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2829-32. PubMed ID: 16870779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida spp.
    Messer SA; Diekema DJ; Boyken L; Tendolkar S; Hollis RJ; Pfaller MA
    J Clin Microbiol; 2006 Feb; 44(2):324-6. PubMed ID: 16455878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro fungicidal activities of anidulafungin, caspofungin, and micafungin against Candida glabrata, Candida bracarensis, and Candida nivariensis evaluated by time-kill studies.
    Gil-Alonso S; Jauregizar N; Cantón E; Eraso E; Quindós G
    Antimicrob Agents Chemother; 2015; 59(6):3615-8. PubMed ID: 25801575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The fungicidal activity and paradoxical effect of caspofungin against yeast. Influence of culture medium and incubation time].
    Cantón E; Pemán J; Romero M; Valentín A; Gobernado M
    Rev Esp Quimioter; 2007 Dec; 20(4):433-41. PubMed ID: 18563217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal activity of micafungin against Candida and Aspergillus spp. isolated from pediatric patients in Japan.
    Ikeda F; Saika T; Sato Y; Suzuki M; Hasegawa M; Mikawa T; Kobayashi I; Tsuji A
    Med Mycol; 2009 Mar; 47(2):145-8. PubMed ID: 18668422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.